Four decades of innovations in the field of interventional cardiology are presented as an example for the great growth of high technology in medicine, side by side with the development of general technology and science.
The aim of this study was to investigate the effect of the GP IIb/IIIa inhibitor abciximab (ReoPro((R))) on the function and interaction of platelets and leukocytes during experimental CPB.
Transfusion of 1 unit of 42-day-stored RBCs to healthy subjects has no overt detrimental effect on tissue oxygenation or the microcirculation assessed by clinically available monitors.
